Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries
Bente Glintborg, Daniela Di Giuseppe, Johan K. Wallman, Dan Nordström, Björn Guðbjörnsson, Merete Lund Hetland, Johan Askling, Gerður Gröndal, Tuulikki Sokka, Sella Aarrestad Provan, Brigitte Michelsen, Eirik Klami Kristianslund, Lene Dreyer, Þorvarður Jón Löve, Ulf Lindström
Topics & Concepts
MedicinePsoriatic arthritisAntirheumatic drugsAntirheumatic AgentsArthritisBiologic AgentsBiosimilarDermatologyDiseasePharmacologyInternal medicineSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research